Quantitative Analysis of Heparanase Gene Expression in Normal Cervical, Cervical Intraepithelial Neoplastic, and Cervical Carcinoma Tissues

被引:7
作者
Varchalama, Eugene [1 ]
Rodolakis, Alexander [1 ]
Strati, Areti [2 ]
Papageorgiou, Theocharis [1 ]
Valavanis, Christos [3 ]
Vorgias, George [4 ]
Lianidou, Evi [2 ]
Antsaklis, Aristidis [1 ]
机构
[1] Univ Athens, Dept Obstet & Gynecol 1, Athens, Greece
[2] Univ Athens, Dept Chem, Analyt Chem Lab, GR-10680 Athens, Greece
[3] Metaxa Mem Canc Hosp, Dept Pathol, Piraeus, Greece
[4] Metaxa Mem Canc Hosp, Dept Gynecol, Piraeus, Greece
关键词
Heparanase; Cervical cancer; Intraepithelial cervical lesion; HEPATOCYTE GROWTH-FACTOR; MAMMALIAN HEPARANASE; SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CELL-SURFACE; KEY ENZYME; CANCER; METASTASIS; TRANSCRIPTION; ANGIOGENESIS;
D O I
10.1111/IGC.0b013e3181ae3f40
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heparanase is an endoglycosidase that specifically cleaves heparan sulfate side chains of heparan sulfate proteoglycans, the major proteoglycans in the extracellular matrix and cell surfaces. Traditionally, heparanase activity was implicated in cellular invasion associated with angiogenesis, inflammation, and cancer metastasis. More recently, heparanase up-regulation was documented in an increasing number of primary human tumors. In this study, we sought to investigate the expression of heparanase messenger RNA (mRNA) in normal cervical tissue and intraepithelial cervical lesion and its clinicopathologic importance in invasive cervical cancer. Gene expression of heparanase was assessed by quantitative real-time reverse transcriptase polymerase chain reaction in 28 normal cervical, 26 intraepithelial neoplastic, and 48 cervical cancer tissue samples. Heparanase mRNA expression was different between the 3 groups and lower in normal cervical specimens in relationship with intraepithelial cervical lesions and invasive cervical cancer tissue samples (P = 0.048). Gradually increasing expression of heparanase was evident as the cells progressed from low-grade to high-grade squamous intraepithelial lesions (P = 0.002). In invasive cervical cancer cases, there was a direct correlation between heparanase expression and tumor size (P = 0.002). In cases treated with radical hysterectomy and pelvic lymphadenectomy, the heparanase mRNA expression was significantly higher in tumors exhibiting lymph vascular space invasion (P = 0.044) and in cases with big tumor size (P = 0.005). In our study, we did not find any significant correlation between disease-free and overall survival rates and expression of heparanase (P = 0.396 and P = 0.712, respectively). The results of this study suggest that the gene expression of heparanase in cervical cancer enhances growth, invasion, and angiogenesis of the tumor and may have therapeutic applications.
引用
收藏
页码:1614 / 1619
页数:6
相关论文
共 42 条
[1]   Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival [J].
Ben-Izhak, Ofer ;
Kaplan-Cohen, Victoria ;
Ilan, Neta ;
Gan, Shlomit ;
Vlodavsky, Israel ;
Nagler, Rafael .
NEOPLASIA, 2006, 8 (10) :879-884
[2]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[3]  
BIAO H, 2005, WORLD J GASTROENTERO, V11, P2188
[4]   Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells [J].
de Mestre, AM ;
Rao, S ;
Hornby, JR ;
Soe-Htwe, T ;
Khachigian, LM ;
Hulett, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) :35136-35147
[5]   Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1 [J].
de Mestre, AM ;
Khachigian, LM ;
Santiago, FS ;
Staykova, MA ;
Hulett, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50377-50385
[6]   Role of endothelial heparanase in delayed-type hypersensitivity [J].
Edovitsky, E ;
Lerner, I ;
Zcharia, E ;
Peretz, T ;
Vlodavsky, I ;
Elkin, M .
BLOOD, 2006, 107 (09) :3609-3616
[7]  
El-Assal ON, 2001, CLIN CANCER RES, V7, P1299
[8]   Heparanase as mediator of angiogenesis: mode of action [J].
Elkin, M ;
Ilan, N ;
Ishai-Michaeli, R ;
Friedmann, Y ;
Papo, O ;
Pecker, I ;
Vlodavsky, I .
FASEB JOURNAL, 2001, 15 (07) :1661-+
[9]  
Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO
[10]  
2-A